| Title | Author(s) | Issue date | ???itemlist.??? |
| Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study | Fountzilas, G.; Polichronis, A.; Katsohis, K.; Gennatas, K.; Toussis, D.; Skarlos, D.; Kosmidis, P.; Vassilaros, S.; Semoglou, C.; Giannakakis, T.; Fahantidis, E.; Klouvas, G.; Tsavaris, N.; Konstantaras, C.; Makrantonakis, P.; Kolotas, C.; Zamboglou, N.; Tsiliakos, S.; Hainoglou, D.; Mylonakis, N.; Pavlidis, N. | 24-Nov-2015 | - |
| Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study | Nicolaides, C.; Fountzilas, G.; Zoumbos, N.; Skarlos, D.; Kosmidis, P.; Pectasides, D.; Karabelis, A.; Giannakakis, T.; Symeonidis, A.; Papadopoulos, A.; Antoniou, F.; Pavlidis, N. | 24-Nov-2015 | - |
| High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group study | Fountzilas, G.; Skarlos, D.; Katsohis, C.; Pavlidis, N.; Giannakakis, T.; Bafaloukos, D.; Fahantidis, E.; Klouvas, G.; Beer, M.; Kosmidis, P. | 24-Nov-2015 | - |
| High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group study | Fountzilas, G.; Skarlos, D.; Pavlidis, N. A.; Makrantonakis, P.; Tsavaris, N.; Kalogera-Fountzila, A.; Giannakakis, T.; Beer, M.; Kosmidis, P. | 24-Nov-2015 | - |
| Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer | Fountzilas, G.; Skarlos, D.; Giannakakis, T.; Athanasiadis, A.; Bafaloukos, D.; Kalogera-Fountzila, A.; Bamia, C.; Pavlidis, N.; Kosmidis, P. | 24-Nov-2015 | - |
| Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study | Pavlidis, N.; Nicolaides, C.; Athanassiadis, A.; Beriatou, K.; Skarlos, D.; Giannakakis, T.; Kosmidis, P.; Karvounis, N.; Fountzilas, G. | 24-Nov-2015 | - |
| A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study | Janinis, J.; Giannakakis, T.; Athanasiadis, A.; Fountzilas, G.; Bafaloukos, D.; Kosmidis, P.; Nikolaides, K.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
| A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study | Fountzilas, G.; Athanassiades, A.; Giannakakis, T.; Briasoulis, E.; Bafaloukos, D.; Kalogera-Fountzila, A.; Onienaoum, A.; Kalofonos, H.; Pectasides, D.; Andreopoulou, E.; Bamia, C.; Kosmidis, P.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
| Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma | Bafaloukos, D.; Pavlidis, N.; Fountzilas, G.; Skarlos, D.; Klouvas, G.; Makrantonakis, P.; Giannakakis, T.; Tsavaris, N.; Kosmidis, P. | 24-Nov-2015 | - |
| Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin | Nicolaides, C.; Giannakakis, T.; Skarlos, D.; Athanassiadis, A.; Fountzilas, G.; Damigos, D.; Pavlidis, N. | 24-Nov-2015 | - |
